| Financial Year |
September 30 2021 |
| Monetary Funds |
517,257,834.96 |
| Held-for-trading Financial Assets |
88,626,469.03 |
| Notes Receivable |
941,378.71 |
| Accounts Receivable |
158,208,775.04 |
| Advances to Suppliers |
11,240,860.39 |
| Other Receivables |
37,404,140.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
57,814,533.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,962,171.45 |
| Total Current Assets |
1,169,449,437.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
292,417.97 |
| Investment Properties |
8,728,559.82 |
| Fixed Assetes |
92,662,689.17 |
| Under-construction Projects |
1,797,182.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
5,065,909.52 |
| Goodwill |
15,877,089.12 |
| Long-Term Deferred and Prepaid Expenses |
9,191,905.68 |
| Deferred Income Tax Assets |
22,837,021.35 |
| Other Non-Current Assets |
3,065,418.36 |
| Sub-Total of Non-Current Assets |
185,078,955.68 |
| Total Assets |
1,354,528,393.24 |
| Short-Term Loans |
50,966,103.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
81,351,035.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,059,131.56 |
| Taxes Payable |
17,987,370.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
238,499,101.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,753,441.41 |
| Other Current Liabilities |
20,223,884.61 |
| Sub-Total of Current Liabilities |
503,830,171.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,227,808.25 |
| Total Liabilities |
518,057,979.59 |
| Paid-In Capital(Or Share Stock) |
206,403,615.00 |
| Capital Surplus |
340,141,407.70 |
| Surplus Reserve |
26,174,338.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
216,903,500.37 |
| Minority Stockholder's Interest |
47,744,566.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
788,725,847.13 |
| Owner's Equity（Stockholder's Equity） |
836,470,413.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,354,528,393.24 |
